Under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirement) Regulation, 2015, Norris Medicines has informed that a meeting of Board of Directors of the Company will be held on Saturday, 02nd February, 2018, to consider and approve unaudited Financial Results of the Company for the quarter ended 31st December, 2017. Further, the trading window shall remain closed from 02nd February, 2018 to 13th February, 2018.
The above information is a part of company’s filings submitted to BSE.
